INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 124 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $97,000 | +29.3% | 12,400 | +8.8% | 0.01% | +30.0% |
| Q1 2017 | $75,000 | -5.1% | 11,400 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $79,000 | -60.3% | 11,400 | -46.7% | 0.01% | -63.0% |
| Q3 2016 | $199,000 | 0.0% | 21,400 | -0.7% | 0.03% | +8.0% |
| Q2 2016 | $199,000 | +4.2% | 21,550 | -1.8% | 0.02% | +8.7% |
| Q1 2016 | $191,000 | -52.7% | 21,950 | -63.5% | 0.02% | -50.0% |
| Q4 2015 | $404,000 | – | 60,170 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Triatomic Management LP | 235,000 | $405,000 | 0.23% |
| Green Alpha Advisors, LLC | 147,380 | $254,000 | 0.22% |
| Financial Advocates Investment Management | 14,161 | $628,000 | 0.05% |
| Virtus ETF Advisers LLC | 72,540 | $125,000 | 0.05% |
| Cedar Brook Financial Partners, LLC | 88,750 | $153,094 | 0.05% |
| Rafferty Asset Management, LLC | 2,363,189 | $4,077,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 352,721 | $608,000 | 0.04% |
| CAXTON ASSOCIATES LP | 130,728 | $226,000 | 0.03% |
| Keystone Financial Group | 74,058 | $128,000 | 0.03% |
| Virtu Financial LLC | 130,829 | $226,000 | 0.02% |